Builders FirstSource
BLDR
$72.72
-0.19%
Builders FirstSource is a leading manufacturer and supplier of building materials, offering structural products like roof trusses, wall panels, windows, and millwork to homebuilders. As the largest supplier of building products in the U.S., it serves production and custom homebuilders with a comprehensive product portfolio and turn-key framing services. The stock is under pressure due to a sharp downturn in housing starts and rising interest rates, which have compressed revenue and margins, leading to a 45% decline over the past year. Investor debate centers on whether the cyclical trough is near and if a recovery in residential construction will drive a rebound.…
BLDR
Builders FirstSource
$72.72
Investment Opinion: Should I buy BLDR Today?
Rating: Hold. The thesis is that BLDR is a cyclical stock near the bottom of its earnings cycle, but with no clear catalyst for a near-term recovery. The consensus analyst rating is Buy with an average target of $97.14, implying 33.3% upside, but the deteriorating fundamentals warrant caution.
Supporting evidence: The forward P/E of 12.2x is at an 18% discount to the industry average of 15x, suggesting value. However, revenue is declining at 10.1% YoY, and the company posted a net loss in Q1 2026. TTM free cash flow of $861.6 million provides a cushion, but the trend is negative. The stock's beta of 1.42 means it could rebound sharply if housing recovers, but also fall further if conditions worsen.
Risks & Conditions: The biggest risks are a prolonged housing downturn and further margin compression. This Hold would upgrade to Buy if housing starts show a sustained recovery or if the stock falls below $65 with no change in fundamentals (value trap risk). It would downgrade to Sell if revenue declines accelerate beyond 15% or if free cash flow turns negative. Overall, BLDR appears fairly valued relative to its cyclical trough earnings, but overvalued on trailing earnings (P/E 26.3x).
Sign up to view all
BLDR 12-Month Price Forecast
BLDR is a high-risk, high-reward cyclical stock. The forward P/E of 12.2x suggests value, but the deteriorating fundamentals and lack of a near-term catalyst argue for caution. The base case of stabilization and gradual recovery is most likely, but the wide range of analyst targets ($70-$133) reflects high uncertainty. A neutral stance is warranted until there is clearer evidence of a housing market trough. An upgrade to bullish would require a sustained improvement in housing data or a significant pullback in the stock below $65. A downgrade to bearish would follow further revenue deterioration or margin compression.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Builders FirstSource's 12-month outlook, with a consensus price target around $97.14 and implied upside of +33.6% versus the current price.
Average Target
$97.14
0 analysts
Implied Upside
+33.6%
vs. current price
Analyst Count
—
covering this stock
Price Range
$70 - $133
Analyst target range
BLDR is covered by 21 analysts, with a consensus recommendation of 'Buy' (mean recommendation 2.27 on a 1-5 scale where 1 is Strong Buy). The average target price is $97.14, implying 33.3% upside from the current price of $72.86. The distribution shows a bullish tilt, with several firms maintaining Overweight or Buy ratings (Keybanc, Benchmark, RBC Capital, UBS, Barclays) and only a few at Neutral/Equal Weight (Wells Fargo, DA Davidson, Stephens & Co., B of A Securities). The target range spans from $70.00 (low) to $133.00 (high). The low target of $70 suggests a scenario where the housing downturn persists, leading to further earnings erosion and multiple compression. The high target of $133 implies a strong recovery in housing starts, margin expansion, and multiple re-rating. The wide spread ($63) indicates high uncertainty about the timing and magnitude of a recovery. Recent ratings have been stable, with no downgrades or upgrades in the past three months, suggesting analysts are waiting for clearer signs of a turnaround. The consensus implies that the stock is undervalued at current levels, but the risk of further downside remains if the macro environment worsens.
Drowning in data?
Find the real signal!
Bulls vs Bears: BLDR Investment Factors
BLDR presents a classic cyclical investment debate. The bull case rests on a low forward P/E of 12.2x, strong free cash flow generation, and the potential for a housing recovery to drive earnings normalization. The bear case highlights accelerating revenue declines, margin compression, and a net loss in the most recent quarter. Currently, the bearish evidence is stronger given the deteriorating fundamentals and lack of a catalyst for a near-term turnaround. The single most important tension is whether the housing market has reached a trough or will continue to weaken; a recovery would validate the bull case, while further deterioration could push the stock below the 52-week low of $65.10.
Bullish
- 33% Upside to Analyst Target: The average analyst target price is $97.14, implying 33.3% upside from the current price of $72.86. With 21 analysts covering the stock and a consensus Buy rating, the market is pricing in a recovery that could materialize as housing starts rebound.
- Low Forward P/E of 12.2x: The forward P/E of 12.2x is at an 18% discount to the construction materials industry average of ~15x. This low multiple suggests the market is pricing in depressed earnings, and if earnings recover as expected, the stock could see multiple expansion.
- Strong Free Cash Flow Generation: TTM free cash flow is $861.6 million, providing a cushion for debt service and potential share buybacks. Despite the Q1 2026 net loss, the company generated positive free cash flow of $40.7 million in the quarter, demonstrating operational resilience.
- Cyclical Recovery Potential: The stock has declined 45.1% over the past year, largely due to a downturn in housing starts. If interest rates stabilize or decline, homebuilding activity could rebound, driving revenue and margin recovery. The stock's beta of 1.42 amplifies upside in a recovery scenario.
Bearish
- Revenue Decline Accelerating: Q1 2026 revenue fell 10.1% year-over-year to $3.287 billion, with all segments showing weakness. This marks the fourth consecutive quarter of declining revenue, and the pace of decline is accelerating from -5% in Q2 2025 to -10% in Q1 2026.
- Net Loss and Margin Compression: The company reported a net loss of $47.4 million in Q1 2026, compared to net income of $96.3 million a year earlier. Gross margin compressed to 28.3% from 30.5%, and operating margin fell to 0.5% from 5.0%, indicating significant operational deleveraging.
- High Debt-to-Equity of 1.30: With a debt-to-equity ratio of 1.30, the company carries moderate leverage. In a prolonged downturn, interest expense of $74.4 million per quarter could strain cash flows, especially if free cash flow continues to decline from the TTM level of $861.6 million.
- Stock in Sustained Downtrend: The stock is down 45.1% over the past year and 14.7% over the past month, underperforming the S&P 500 by 61.6% and 15.5%, respectively. The price is only 8.3% above the 52-week low of $65.10, with no signs of a trend reversal.
BLDR Technical Analysis
BLDR is in a sustained downtrend, with the stock price falling 45.1% over the past year compared to the S&P 500's gain of 16.5%. The current price of $72.86 sits at just 8.3% above the 52-week low of $65.10 and 51.8% below the 52-week high of $151.03, indicating significant bearish momentum and positioning near the bottom of its range. This suggests the market is pricing in continued weakness, though value-oriented investors may see a potential bottom if fundamentals stabilize. Short-term momentum remains negative, with the stock down 14.7% over the past month and 19.1% over the past three months, underperforming the S&P 500 by 15.5% and 22.6%, respectively. The 1-month decline is accelerating relative to the 3-month trend, signaling persistent selling pressure without signs of reversal. The relative strength index (RSI) is not provided, but the consistent price erosion suggests oversold conditions may be developing, though no confirmation is available. Key support lies at the 52-week low of $65.10, a break below which could open the door to further downside toward $60. Resistance is at the 52-week high of $151.03, but nearer-term resistance is around $90, the level from early July. A breakout above $90 would signal a potential trend reversal, while a breakdown below $65 would confirm continued bearishness. With a beta of 1.42, BLDR is 42% more volatile than the market, amplifying both downside risk and potential upside in a recovery scenario.
Beta
1.42
1.42x market volatility
Max Drawdown
-55.5%
Largest decline past year
52-Week Range
$65-$151
Price range past year
Annual Return
-46.7%
Cumulative gain past year
| Period | BLDR Return | S&P 500 |
|---|---|---|
| 1m | -18.4% | +1.4% |
| 3m | -17.5% | +3.9% |
| 6m | -37.9% | +6.3% |
| 1y | -46.7% | +16.0% |
| ytd | -30.5% | +8.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
BLDR Fundamental Analysis
Revenue has been declining, with the most recent quarter (Q1 2026) showing revenue of $3.287 billion, down 10.1% year-over-year. This follows a trend of decelerating growth: Q2 2025 revenue was $4.234 billion (down from $4.456 billion in Q2 2024), and Q3 2025 revenue was $3.941 billion (down from $4.232 billion in Q3 2024). The decline is broad-based, with all segments—Lumber & Sheet Goods ($845M), Manufactured Products ($735M), Specialty Products ($853M), and Windows, Doors & Millwork ($854M)—showing weakness. The revenue trajectory reflects a cyclical downturn in housing, and the investment case hinges on a recovery in homebuilding activity. Profitability has deteriorated sharply. The company reported a net loss of $47.4 million in Q1 2026, compared to net income of $96.3 million in Q1 2025, with EPS of -$0.43. Gross margin compressed to 28.3% from 30.5% a year ago, and operating margin fell to 0.5% from 5.0%. The net margin turned negative at -1.4%. The company is still generating positive EBITDA of $164.9 million, but the trend is concerning. If housing demand does not recover, margins could remain under pressure. The balance sheet shows moderate leverage with a debt-to-equity ratio of 1.30 and a current ratio of 1.86, indicating adequate liquidity. Free cash flow was $40.7 million in Q1 2026, down from $32.4 million in Q1 2025, but the TTM free cash flow is $861.6 million, providing a cushion. ROE is 10.0% on a trailing basis, but the recent loss will weigh on returns. The company does not pay a dividend, relying on reinvestment and share buybacks (though buybacks were reduced in Q1 2026). Overall, financial health is manageable but weakening.
Quarterly Revenue
$3.3B
2026-03
Revenue YoY Growth
-10.1%
YoY Comparison
Gross Margin
28.3%
Latest Quarter
Free Cash Flow
$861639000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is BLDR Overvalued?
Since net income is positive on a trailing twelve-month basis (TTM net income is positive despite Q1 loss), we use the P/E ratio as the primary valuation metric. The trailing P/E is 26.3x, while the forward P/E is 12.2x, implying the market expects a sharp earnings recovery. The wide gap between trailing and forward P/E suggests that current earnings are depressed and the market is pricing in a normalization. The P/S ratio of 0.75x is low, reflecting the cyclical trough. Compared to the construction materials industry, BLDR's forward P/E of 12.2x is at a discount to the industry average of approximately 15x (based on available data), representing an 18% discount. This discount is justified by the company's negative revenue growth and compressed margins, but if housing recovers, the discount could narrow. The P/B ratio of 2.63x is above the industry average of 1.5x, indicating the market values its asset base. Historically, BLDR's trailing P/E has ranged from 2.3x (in 2022) to 91.9x (in Q4 2025). The current 26.3x is near the middle of this range but elevated relative to the 2022-2023 period when earnings were strong. The forward P/E of 12.2x is near the lower end of its historical forward range, suggesting the stock is pricing in a recovery. If earnings rebound as expected, the current valuation could be attractive, but if the downturn persists, the stock could de-rate further.
PE
26.3x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 2x~37x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
12.3x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: BLDR's financial health is weakening. Revenue declined 10.1% YoY in Q1 2026, and the company posted a net loss of $47.4 million, compared to net income of $96.3 million a year ago. Gross margin compressed to 28.3% from 30.5%, and operating margin fell to 0.5% from 5.0%. The debt-to-equity ratio of 1.30 indicates moderate leverage, and interest expense of $74.4 million per quarter consumes a significant portion of EBITDA ($164.9 million in Q1). If the downturn persists, free cash flow (TTM $861.6 million) could decline further, potentially leading to covenant issues or reduced financial flexibility.
Market & Competitive Risks: The stock is highly correlated to the housing cycle, with a beta of 1.42 amplifying downside. The 45.1% decline over the past year reflects the market's repricing of cyclical risk. The forward P/E of 12.2x, while low, could compress further if earnings estimates are cut. Competition from other building materials suppliers could pressure margins, and regulatory changes (e.g., tariffs on lumber) could increase input costs. The stock's 52-week low of $65.10 is only 8.3% below the current price, offering limited downside protection.
Worst-Case Scenario: If housing starts continue to decline and interest rates remain elevated, BLDR could see further revenue contraction and margin erosion. In a severe downturn, the stock could fall to the analyst low target of $70.00 or below the 52-week low of $65.10, implying a potential loss of 10.6% from the current price. A break below $65 could trigger further selling, with a realistic downside to $60, representing a 17.6% loss. The historical max drawdown of -55.5% suggests that in a worst-case scenario, the stock could revisit levels near $32, though this would require a severe housing crisis.
FAQ
The primary risk is a prolonged housing downturn, which would further reduce revenue and margins. Financial risk includes a debt-to-equity ratio of 1.30 and interest expense of $74.4 million per quarter, which could strain cash flows. Market risk is high due to a beta of 1.42, amplifying losses in a bear market. Company-specific risks include potential share buyback reductions and the lack of a dividend. The most severe risk is a break below the 52-week low of $65.10, which could trigger further selling.
Analysts forecast a 12-month price range of $70 to $133, with an average target of $97.14 (33.3% upside). The base case (50% probability) sees stabilization and a gradual recovery, with the stock trading between $80 and $100. The bull case (25% probability) targets $100-$133 on a strong housing recovery. The bear case (25% probability) sees the stock falling to $60-$75 if the downturn deepens. The most likely scenario is the base case, assuming housing starts bottom in H2 2026.
On a trailing P/E of 26.3x, BLDR appears overvalued relative to its depressed earnings. However, the forward P/E of 12.2x suggests the market expects a sharp earnings recovery, making it undervalued on a forward basis. Compared to the construction materials industry average forward P/E of 15x, BLDR trades at an 18% discount. The P/S ratio of 0.75x is low, reflecting the cyclical trough. Overall, the stock is undervalued if earnings recover as expected, but overvalued if the downturn persists.
BLDR offers a compelling risk/reward for investors with a cyclical outlook. The average analyst target of $97.14 implies 33.3% upside, and the forward P/E of 12.2x is at a discount to the industry. However, the stock is in a downtrend with declining revenue and a net loss in Q1 2026. It is a good buy only for those who believe the housing market is near a trough and can tolerate high volatility (beta 1.42). Conservative investors should wait for clearer signs of a recovery before buying.
BLDR is best suited for medium-term investors with a 12-24 month horizon who can ride out the cyclical downturn. The stock's high beta (1.42) and 45% decline over the past year make it unsuitable for short-term trading due to high volatility and negative momentum. Long-term investors may benefit from a housing recovery, but the cyclical nature means it is not a buy-and-hold forever stock. A minimum holding period of 12 months is recommended to allow for a potential recovery.
